Abstract
Purpose
Using data from a large population-based cohort of women with fertility problems in Denmark, we examined the association between use of fertility drugs and endometrial cancer incidence.
Methods
Women aged 20–45 years living in Denmark during 1 January 1995–31 December 2017 and diagnosed with fertility problems (i.e., subfertile women) were identified from the Danish Infertility Cohort. Information on use of fertility drugs, endometrial cancer, covariates and vital status was obtained from various Danish national registers. Cox proportional hazard models were used adjusted for calendar year of study entry, highest level of education, parity status, hormonal contraceptive use, obesity and diabetes mellitus.
Results
Of the 146,104 subfertile women, 129,478 (88.6%) were treated with fertility drugs. During a median follow-up of 10.1 years, 119 women were diagnosed with endometrial cancer. Use of any fertility drugs was not associated with an increased rate of overall (HR 0.82; 95% CI 0.50–1.34) or type I endometrial cancer (HR 1.08; 95% CI 0.60–1.95). No associations between use of specific types of fertility drugs and endometrial cancer were observed. No marked associations were observed according to cumulative dose of specific fertility drugs, parity status, or with increasing follow-up time.
Conclusions
No marked associations between use of fertility drugs and risk of endometrial cancer were observed. The relatively young age of the cohort at end of follow-up, however, highlights the need for longer follow-up of women after fertility drug use
Similar content being viewed by others
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31(20):2607–2618
Jones ME, van Leeuwen FE, Hoogendoorn WE et al (2012) Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries. Breast Cancer Res 14(3):R91
Felix AS, Yang HP, Gierach GL, Park Y, Brinton LA (2014) Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity. Cancer Causes Control 25(4):479–489
Althuis MD, Moghissi KS, Westhoff CL et al (2005) Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161(7):607–615
Modan B, Ron E, Lerner-Geva L et al (1998) Cancer incidence in a cohort of infertile women. Am J Epidemiol 147(11):1038–1042
Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A (1999) Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71(5):853–859
Silva Idos S, Wark PA, McCormack VA et al (2009) Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort. Br J Cancer 100(11):1824–1831
Brinton LA, Westhoff CL, Scoccia B et al (2013) Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod 28(10):2813–2821
Doyle P, Maconochie N, Beral V, Swerdlow AJ, Tan SL (2002) Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 17(8):2209–2213
Williams CL, Jones ME, Swerdlow AJ et al (2018) Risks of ovarian, breast, and corpus uteri cancer in women treated with assisted reproductive technology in Great Britain, 1991–2010: data linkage study including 2.2 million person years of observation. BMJ 362:k2644
Reigstad MM, Larsen IK, Myklebust TA et al (2015) Cancer risk among parous women following assisted reproductive technology. Hum Reprod 30(8):1952–1963
Venn A, Watson L, Bruinsma F, Giles G, Healy D (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354(9190):1586–1590
Calderon-Margalit R, Friedlander Y, Yanetz R et al (2009) Cancer risk after exposure to treatments for ovulation induction. Am J Epidemiol 169(3):365–375
Lerner-Geva L, Rabinovici J, Olmer L, Blumstein T, Mashiach S, Lunenfeld B (2012) Are infertility treatments a potential risk factor for cancer development? Perspective of 30 years of follow-up. Gynecol Endocrinol 28(10):809–814
Jensen A, Sharif H, Kjaer SK (2009) Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study. Am J Epidemiol 170(11):1408–1414
Dor J, Lerner-Geva L, Rabinovici J et al (2002) Cancer incidence in a cohort of infertile women who underwent in vitro fertilization. Fertil Steril 77(2):324–327
Kessous R, Davidson E, Meirovitz M, Sergienko R, Sheiner E (2016) The risk of female malignancies after fertility treatments: a cohort study with 25-year follow-up. J Cancer Res Clin Oncol 142(1):287–293
Skalkidou A, Sergentanis TN, Gialamas SP et al (2017) Risk of endometrial cancer in women treated with ovary-stimulating drugs for subfertility. Cochrane Database Syst Rev 3:Cd010931
WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2019. https://www.whocc.no/filearchive/publications/2019_guidelines_web.pdf
R Core Team (2013) R: a language and environment for statistical computing. https://www.R-project.org
Parazzini F, Pelucchi C, Talamini R, Montella M, La Vecchia C (2010) Use of fertility drugs and risk of endometrial cancer in an Italian case–control study. Eur J Cancer Prev 19(6):428–430
Parazzini F, Ricci E, Rosa C, Negri E, La Vecchia C (2001) Risk of endometrial cancer after use of fertility drugs. Hum Reprod 16(1):196
Benshushan A, Paltiel O, Brzezinski A et al (2001) Ovulation induction and risk of endometrial cancer: a pilot study. Eur J Obstet Gynecol Reprod Biol 98(1):53–57
Preston-Martin S, Pike MC, Ross RK, Henderson BE (1993) Epidemiologic evidence for the increased cell proliferation model of carcinogenesis. Environ Health Perspect 101(Suppl 5):137–138
Nakamura Y, Ono M, Yoshida Y, Sugino N, Ueda K, Kato H (1997) Effects of clomiphene citrate on the endometrial thickness and echogenic pattern of the endometrium. Fertil Steril 67(2):256–260
Miannay E, Boutemy JJ, Leroy-Billiard M, Gasnault JP, Leroy JL (1994) The possible endometrial risk of ovarian stimulation. J Gynecol Obstet Biol Reprod (Paris) 23(1):35–38
Brinton LA, Trabert B, Shalev V, Lunenfeld E, Sella T, Chodick G (2013) In vitro fertilization and risk of breast and gynecologic cancers: a retrospective cohort study within the Israeli Maccabi Healthcare Services. Fertil Steril 99(5):1189–1196
Acknowledgments
We would like to thank Rasmus Hertzum-Larsen for data extraction.
Funding
The study was supported by research grants from the Danish Cancer Society’s Scientific Committee (R146-A9249-16-S2), the Novo Nordisk Foundation (NNF18OC0052346), the Jascha Foundation (5570) and the Aase and Ejner Danielsens Foundation (10-001599).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare no competing financial interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Guleria, S., Jensen, A., Albieri, V. et al. Endometrial cancer risk after fertility treatment: a population-based cohort study. Cancer Causes Control 32, 181–188 (2021). https://doi.org/10.1007/s10552-020-01372-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-020-01372-3